Novocure Names Christoph Brackmann Chief Financial Officer

Dow Jones10-30 19:43
 

By Colin Kellaher

 

Novocure has hired Christoph Brackmann as the oncology company's next chief financial officer.

Novocure on Wednesday said Brackmann, who was previously senior vice president of finance at Moderna, joins the Switzerland-based company immediately as a senior financial adviser and will become finance chief on Jan. 1, when Ashley Cordova is slated to become chief executive.

Novocure said Brackmann will receive an annual base salary of 450,000 Swiss francs ($519,000) and is eligible for an annual cash bonus with a target of 60% of his base pay.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

October 30, 2024 07:43 ET (11:43 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment